275 related articles for article (PubMed ID: 12091424)
1. Retinal microenvironment controls resident and infiltrating macrophage function during uveoretinitis.
Robertson MJ; Erwig LP; Liversidge J; Forrester JV; Rees AJ; Dick AD
Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2250-7. PubMed ID: 12091424
[TBL] [Abstract][Full Text] [Related]
2. Neutralizing tumor necrosis factor-alpha activity suppresses activation of infiltrating macrophages in experimental autoimmune uveoretinitis.
Robertson M; Liversidge J; Forrester JV; Dick AD
Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):3034-41. PubMed ID: 12824249
[TBL] [Abstract][Full Text] [Related]
3. Resident and infiltrating immune cells in the uveal tract in the early and late stages of experimental autoimmune uveoretinitis.
Butler TL; McMenamin PG
Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2195-210. PubMed ID: 8843906
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of tumor necrosis factor activity minimizes target organ damage in experimental autoimmune uveoretinitis despite quantitatively normal activated T cell traffic to the retina.
Dick AD; McMenamin PG; Körner H; Scallon BJ; Ghrayeb J; Forrester JV; Sedgwick JD
Eur J Immunol; 1996 May; 26(5):1018-25. PubMed ID: 8647162
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide accelerates the onset and increases the severity of experimental autoimmune uveoretinitis through an IFN-gamma-dependent mechanism.
Hoey S; Grabowski PS; Ralston SH; Forrester JV; Liversidge J
J Immunol; 1997 Nov; 159(10):5132-42. PubMed ID: 9366443
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of nitric oxide synthase in experimental uveoretinitis.
Zhang J; Wu LY; Wu GS; Rao NA
Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):1899-905. PubMed ID: 10440241
[TBL] [Abstract][Full Text] [Related]
7. Macrophages and dendritic cells in IRBP-induced experimental autoimmune uveoretinitis in B10RIII mice.
Jiang HR; Lumsden L; Forrester JV
Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3177-85. PubMed ID: 10586940
[TBL] [Abstract][Full Text] [Related]
8. T cell traffic and the inflammatory response in experimental autoimmune uveoretinitis.
Prendergast RA; Iliff CE; Coskuncan NM; Caspi RR; Sartani G; Tarrant TK; Lutty GA; McLeod DS
Invest Ophthalmol Vis Sci; 1998 Apr; 39(5):754-62. PubMed ID: 9538882
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibody-mediated CD200 receptor signaling suppresses macrophage activation and tissue damage in experimental autoimmune uveoretinitis.
Copland DA; Calder CJ; Raveney BJ; Nicholson LB; Phillips J; Cherwinski H; Jenmalm M; Sedgwick JD; Dick AD
Am J Pathol; 2007 Aug; 171(2):580-8. PubMed ID: 17600119
[TBL] [Abstract][Full Text] [Related]
10. Distribution of OX2 antigen and OX2 receptor within retina.
Dick AD; Broderick C; Forrester JV; Wright GJ
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):170-6. PubMed ID: 11133863
[TBL] [Abstract][Full Text] [Related]
11. IL-18 not required for IRBP peptide-induced EAU: studies in gene-deficient mice.
Jiang HR; Wei X; Niedbala W; Lumsden L; Liew FY; Forrester JV
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):177-82. PubMed ID: 11133864
[TBL] [Abstract][Full Text] [Related]
12. Oral administration of interferon-beta suppresses experimental autoimmune uveoretinitis.
Suzuki J; Sakai J; Okada AA; Takada E; Usui M; Mizuguchi J
Graefes Arch Clin Exp Ophthalmol; 2002 Apr; 240(4):314-21. PubMed ID: 11981647
[TBL] [Abstract][Full Text] [Related]
13. Initial cytokine exposure determines function of macrophages and renders them unresponsive to other cytokines.
Erwig LP; Kluth DC; Walsh GM; Rees AJ
J Immunol; 1998 Aug; 161(4):1983-8. PubMed ID: 9712070
[TBL] [Abstract][Full Text] [Related]
14. Neutralizing TNF-alpha activity modulates T-cell phenotype and function in experimental autoimmune uveoretinitis.
Dick AD; Duncan L; Hale G; Waldmann H; Isaacs J
J Autoimmun; 1998 Jun; 11(3):255-64. PubMed ID: 9693974
[TBL] [Abstract][Full Text] [Related]
15. Experimental autoimmune uveoretinitis (EAU)-related tissue damage and angiogenesis is reduced in CCL2⁻/⁻CX₃CR1gfp/gfp mice.
Zhao J; Chen M; Xu H
Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7572-82. PubMed ID: 25342612
[TBL] [Abstract][Full Text] [Related]
16. Expression of major histocompatibility complex molecules in rodent retina. Immunohistochemical study.
Zhang J; Wu GS; Ishimoto S; Pararajasegaram G; Rao NA
Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1848-57. PubMed ID: 9286275
[TBL] [Abstract][Full Text] [Related]
17. Intranasal administration of retinal antigens induces transient T cell activation and apoptosis within drainage lymph nodes but not spleen.
Laliotou B; Duncan L; Dick AD
J Autoimmun; 1999 May; 12(3):145-55. PubMed ID: 10222024
[TBL] [Abstract][Full Text] [Related]
18. Amelioration of experimental autoimmune uveoretinitis with nuclear factor-{kappa}B Inhibitor dehydroxy methyl epoxyquinomicin in mice.
Iwata D; Kitaichi N; Miyazaki A; Iwabuchi K; Yoshida K; Namba K; Ozaki M; Ohno S; Umezawa K; Yamashita K; Todo S; Ishida S; Onoé K
Invest Ophthalmol Vis Sci; 2010 Apr; 51(4):2077-84. PubMed ID: 19907030
[TBL] [Abstract][Full Text] [Related]
19. Analysis of retinal cellular infiltrate in experimental autoimmune uveoretinitis reveals multiple regulatory cell populations.
Kerr EC; Raveney BJ; Copland DA; Dick AD; Nicholson LB
J Autoimmun; 2008 Dec; 31(4):354-61. PubMed ID: 18838247
[TBL] [Abstract][Full Text] [Related]
20. High mobility group box protein-1 in experimental autoimmune uveoretinitis.
Watanabe T; Keino H; Sato Y; Kudo A; Kawakami H; Okada AA
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2283-90. PubMed ID: 19151394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
